Bicycle Therapeutics plc (BCYC)
NASDAQ: BCYC · Real-Time Price · USD
5.38
+0.18 (3.46%)
At close: Mar 9, 2026, 4:00 PM EDT
5.28
-0.10 (-1.86%)
After-hours: Mar 9, 2026, 4:35 PM EDT

Bicycle Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2016
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2016
Market Capitalization
3739677678791,790382
Upgrade
Market Cap Growth
-53.64%26.03%-12.72%-50.89%367.95%126.52%
Upgrade
Enterprise Value
-274872415611,563248
Upgrade
Last Close Price
5.2014.0018.0829.6060.8717.95
Upgrade
PS Ratio
13.0127.4028.4360.76152.9936.81
Upgrade
PB Ratio
0.581.222.073.255.174.01
Upgrade
P/TBV Ratio
0.601.222.073.255.174.01
Upgrade
EV/Sales Ratio
-2.468.9238.82133.6323.90
Upgrade
Debt / Equity Ratio
0.010.010.120.160.130.17
Upgrade
Net Debt / Equity Ratio
-1.04-1.10-1.30-1.09-1.14-1.26
Upgrade
Net Debt / EBITDA Ratio
2.274.292.632.616.142.37
Upgrade
Net Debt / FCF Ratio
2.665.247.582.8123.446.33
Upgrade
Asset Turnover
0.030.050.050.030.040.08
Upgrade
Quick Ratio
10.3313.617.926.7612.436.51
Upgrade
Current Ratio
10.6613.818.086.9312.656.73
Upgrade
Return on Equity (ROE)
-34.59%-29.04%-56.31%-36.54%-30.25%-54.08%
Upgrade
Return on Assets (ROA)
-20.59%-16.90%-23.60%-16.38%-12.80%-23.94%
Upgrade
Return on Capital Employed (ROCE)
-41.70%-23.60%-36.10%-32.70%-14.80%-37.60%
Upgrade
Earnings Yield
-67.99%-17.49%-23.55%-12.83%-3.73%-13.34%
Upgrade
FCF Yield
-65.60%-17.17%-8.29%-11.96%-0.94%-4.96%
Upgrade
Buyback Yield / Dilution
-34.28%-63.54%-20.00%-18.35%-30.90%-73.34%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.